Background and objective: Obstructive sleep apnoea is a prevalent and considerably underdiagnosed disease. The development of cost-effective, home-based, automatic diagnostic devices to improve the diagnosis accessibility is therefore essential. Methods: In this study, a new portable polygraph (BTIAPNiA) was used to validate automatic scoring. This five-channel device records respiratory flow, oxygen saturation, heart rate, body position and snoring. The validation was performed in two phases. In the first phase, manual and automatic scorings of a new respiratory polygraphy (RP) device (BTI-APNiA) were compared. In the second phase, automatic analysis performed with BTI-APNiA was compared with manual scoring of a validated RP device (Embletta Gold). 
INTRODUCTION
Obstructive sleep apnoea (OSA) is a considerably prevalent disease. [1] [2] [3] [4] A recent Swiss study suggested that the prevalence of OSA could be higher than 50% in some populations. 5 OSA is a risk factor for arterial hypertension and traffic accidents. 3, [6] [7] [8] [9] [10] [11] Moreover, OSA also plays a role in cardiovascular and cerebrovascular complications, 9, [12] [13] [14] and increases the mortality. [15] [16] [17] However, it is estimated that only 10% of the people with this sleep-disordered breathing are diagnosed and treated. 4, [18] [19] [20] Polysomnography (PSG) is the gold-standard to diagnose OSA; however, it is time-consuming and expensive. PSG cannot respond to the high demand for diagnosis. Home sleep studies with portable monitoring devices have been proposed as an alternative to
SUMMARY AT A GLANCE
The portable respiratory polygraph tested here is a valid device for the diagnosis of obstructive sleep apnoea (OSA). The automatic analysis is as accurate as manual analysis of the apnoea-hypopnoea index (AHI). Reliable and accurate devices for automatic diagnosis of OSA may assist to address the underdiagnosis of OSA in the general population.
PSG to reduce costs and facilitate the diagnostic process. 21, 22 Respiratory polygraphy (RP) is a cheaper alternative that has shown significant results. [23] [24] [25] [26] Automatic analysis of respiratory events would, theoretically, be the most cost-effective alternative and some studies have shown acceptable results. [27] [28] [29] [30] [31] [32] [33] [34] Automatic scoring is simpler and cheaper; however, manual scoring gives better results compared with PSG. 34 Therefore, the development of better automatic scoring softwares to be applied in RP performed at home is required.
The hypothesis of this study is that automatic analysis of an RP is as accurate as manual analysis by an expert. To this end, the study was conducted in two phases. During the first phase, manual and automatic scorings of a new RP device (BTI-APNiA) were compared. In the second phase, we performed a validation of the automatic scoring of the BTI-APNiA by comparing it with the manual scoring of a validated RP device (Embletta Gold; ResMed, Kanata, Ontario, Canadá).
METHODS
This manuscript was written according to the STROBE (Strengthening the Reporting of Observational studies in Epidemiology) guidelines.
Patients
Patients were recruited between September 2014 and December 2015 at a sleep clinic in Vitoria, Alava, Spain. The inclusion criteria were: aged more than 18 years, referred for clinically suspected OSA because of snoring, observed apnoeas, sleepiness or morning tiredness. The exclusion criteria were: previous evaluation of OSA, having another sleep disorder, severe and unstable heart disease, incapable of setting up the RP device and refusal to participate in the study.
Sleep studies
All sleep studies were performed at the patient's home. All patients provided a written informed consent and the study received approval by the local ethics committee.
Phase I was aimed at comparing the automatic and manual (by expert) analyses of BTI-APNiA RP (Appendix S1, Supplementary Information). Patients with clinically suspected OSA underwent a sleep study with BTI-APNiA. This device has five channels: respiratory flow, oxygen saturation, cardiac frequency, corporal position and snoring (Fig. S1 , Supplementary Information). It corresponds to classification III of the AASM 35 and the S 3 C 4 O 1 P 2 E 4 R 2 of SCOPER classification. 36 Phase II was performed by comparing automatic analysis of BTI-APNiA against the RP system (Embletta Gold). [37] [38] [39] Both devices included a nasal air flow with a probe connected to a transducer (Embletta also use an oronasal thermistor), cutaneous pulse oximetry (finger probe model 7000A and Modl XPOD 3012LP; Nonin Medical; Plymouth, MN, USA), inductive plethysmography (to assess the abdominal and thoracic effort) and an electrocardiogram (only for Embletta). All sleep studies were analysed according to the guidelines of the Spanish Respiratory Society and the American Academy of Sleep Medicine. 4, 40, 41 The manual analysis was performed by a sleep technician from the sleep unit of the OSI Araba University hospital, Vitoria, Spain. The results of automatic and manual analyses were blinded to each other. A respiratory event was identified as apnoea if it had a duration ≥10 s and the drop in respiratory signal was >90% of the amplitude of the reference respiratory air flow. 42 However, if the drop in the respiratory signal was between 30% and 90%, accompanied by a drop in oxygen saturation ≥3%, the respiratory event was identified as hypopnoea. 42 The desaturation index was defined as the number of times per hour of recording that the blood's oxygen level drops by 3% or more from baseline. If technical problems compromised the quality of the recordings, the study was repeated for a maximum of two times in <2 weeks.
Epworth Sleepiness Scale score, 43 alcohol, smoking, drug intake and the occurrence of systemic diseases were recorded.
Statistical analysis
The comparison of continuous variables was performed by t-test (normal distribution) or Wilcoxon signed-rank test (not normal distribution). For categorical variables, chi-square test was applied (the Bonferroni adjustment was selected when necessary).
Separate receiver operating characteristic (ROC) curves were performed for the BTI-APNiA device (manual and automatic scorings) and for the Embletta Gold device using several apnoea-hypopnoea index (AHI) cut-off points (from ≥5 to ≥30/h), to establish the best area under the curve (AUC) measurements and its evolution according to the severity of the disease. For each cut-off point of AHI, we obtained the sensitivity, specificity, positive and negative predictive values, and positive and negative likelihood ratios. We also determined the greatest AUC for all cut-off points. Finally, we performed a Bland-Altman analysis 44 to compare the results.
Correlation analysis was performed using Pearson's coefficient and the interclass correlation coefficient (ICC). For all variables of the AHI and its severity, we used the mean comparison for related samples and also determined the Kappa index with quadratic weighting. All results were expressed with its 95% CI. SPSS 15.0 (SPSS, IBM, Chicago, Illinois, USA) was used to perform the statistical analysis (P-value < 0.05).
RESULTS

Phase I
Four hundred and seventy-one patients were selected, of whom 424 (90%) fulfilled the inclusion criteria. A total of 47 patients (10%) were excluded because they did not meet the inclusion criteria (n = 12; 2.5%) or because of the technical reasons with the device (n = 35; 7.4%) (Fig. 1) .
Most of the patients (50.5%) were males, had a mean age of 56.2 AE 12.4 years (Table 1) , were ex-smokers and the prevalence of systemic hypertension was 21.9%. The patients were slightly overweight (25.4 AE 4.8 kg/m 2 ) and the Epworth Sleepiness Scale score was 8.0 AE 4.0. Thirty-nine patients had respiratory co-morbidities. Twenty-one had COPD and 18 had asthma. Table 2 shows that the majority of the measurements obtained were not statistically different. The time of valid recording was slightly higher in the automatic scoring. The AHI and the total number of respiratory events were similar in both scorings, but their classification into apnoeas and hypopnoeas showed differences: number of apnoeas was 45.7 AE 68.5 versus 52.8 AE 69.9 for manual and automatic scoring, respectively (P < 0.01) and number of hypopnoeas was 51.9 AE 41.2 versus 45.6 AE 37.6 for manual and automatic scoring, respectively (P < 0.01). Moreover, automatic scorings estimated apnoeas and hypopnoeas to be longer (30.2 AE 6.6 s vs 24.8 AE 6.0 s; P < 0.01).
The comparison of automatic and manual readings was not significantly different (Fig. S2, Supplementary  Information) . The ICC was 0.99 (P < 0.001). Classification of the severity of apnoea-hypopnoea events was also analysed (Fig. S3, Supplementary Information) . The global Kappa index weighted by quadratic weights was 0.91 (95% CI: 0.89-0.93).
A Bland-Altman plot showed a compact distribution indicating the absence of significant differences between automatic and manual readings ( Fig. 2A) . The mean of difference was 0.334 (95% CI: −4.574 to +5.318). The accuracy of both scorings for diagnosing OSA is shown in Table 3 . The AUC was between 0.98 and 0.99 for all items.
Phase II
Forty-six patients were identified, of whom 31 were included. A total 28 patients were included for the study. The most common reason to decline participation was work duties (Fig. 1) .
Most of the patients (72%) were males, had a mean age of 49.1 AE 10.9 years (Table 1) , were ex-smokers and systemic hypertension was present in 26.9%. BMI was 27.1 AE 4.2 kg/m 2 and the Epworth sleepiness scale was 7.5 AE 4.2. Moreover, two patients had COPD and one had asthma. Table 2 shows the absence of significant differences in the AHI and in the total numbers of apnoeahypopnoea events. However, differences were found in the time of valid recording, AHI by position, number of apnoeas, number of hypopnoeas, duration of respiratory events and percentage of the valid recording time under 90% of oxygen saturation. Figure 1 Flow chart of the two phases of the study. The results of the validation of the automatic scoring of BTI-APNiA (Fig. S2, Supplementary Information) showed that there were no statistically significant differences and that the ICC was 0.68 (P < 0.05). The correlation in the classification of OSA according to its severity was also analysed (Fig. S3, Supplementary  Information) . The global Kappa index weighted by quadratic weights was 0.64 (95% CI: 0.44-0.80).
The Bland-Altman plot showed no significant differences (Fig. 2B) . The mean of difference was −1.066 (95% CI: −7.679 to +5.547). The accuracy of both tests in the diagnosis of OSA is shown in Table 4 . The AUC was between 0.96 and 1.00 for all items.
DISCUSSION
This study shows that the automatic analysis of a home RP recorded with a portable device (BTI-APNiA) is as accurate as the manual analysis (by expert) in the diagnosis of OSA. Furthermore, the validation of the diagnosis against Embletta Gold polygraphy showed a significant agreement between both devices.
Several advantages have been achieved by the introduction of RP including the cost-effectiveness and the attendance of a higher number of patients. 4, [21] [22] [23] [24] [25] 34 However, studies so far indicated that RP requires manual analysis by an expert and, therefore, its use per se has not solved the high demand for the diagnosis of OSA. 4, 19, 45 Automatic analysis of RP and a sleep study at home have the potential to reduce the underdiagnoses of OSA. The first studies to validate automatic sleep analysis reported modest, although, relevant outcomes. [46] [47] [48] Indeed, automatic analysis was shown to be effective in identifying the presence of OSA but provided a limited capacity to exclude OSA. 34, [46] [47] [48] This limited validity, combined with the low demand by sleep medicine specialists, may have been a negative stimulus for investigation in this field. In other medical applications, such as in cardiology, automatic analysis has been adapted to make critical decision effectively (e.g. automatic electronic defibrillator). 49 The recent availability of new RPs has reactivated the interest in automatic analysis for the diagnosis of OSA, 43 with promising outcomes. [27] [28] [29] [30] [31] [32] [33] Wong et al., in a PSGcontrolled study, performed an RP study during three consecutive nights at the patient's home. 27 The AUC for PSG AHI ≥ 10 was 0.96. Rofail et al. have reported significant results for the automatic analysis of RP recordings during three consecutive nights. 29 In another study, the same authors reported AUC of 0.92 (95% CI: 0.88-0.96) for AHI ≥ 30. 32 Ragette et al. have compared RP and PSG studies performed both at in-laboratory and the patient's home. 28 The correlation coefficients were 0.98 (bias: −0.7) and 0.95 (bias: −0.6) for the inlaboratory and home settings, respectively. Watkins et al. have performed another study where drivers with high probability of OSA were recruited. 30 A significant correlation was found between the PSG and the automatic analysis of the RP. However, the negative predictive value (0.87) was better than the positive predictive value (0.64). Erman et al. reported significant results for the identification of patients with AHI ≥ 15 (sensitivity of 0.91 and specificity of 0.95). 31 The comparison of RP performed in-laboratory and that performed at the patient's home has also provided significant results. Oktay et al. reported a significant agreement level between home and in-laboratory RP and also between RP and PSG. 33 In a recent PSG-controlled study (752 patients), Masa et al. have reported significant outcomes for the automatic and manual analysis of RP. 25 Manual analysis was better to identify patients with AHI < 15, otherwise both analyses had similar outcomes. In summary, although the automatic analysis has satisfactory outcomes, manual analysis by an expert appears to be superior 34,50,51 and more cost-effective. 34 In this study, there were no significant differences in the AHI between manual and automatic analyses. However, automatic diagnosis overestimated sleep time and the number of apnoeas. These differences were observed in both Phases I and II. Although the automatic analysis overestimated the number of apnoea events, this error does not significantly affect the assessment of the AHI. The automatic analysis, when validated by Embletta Gold, resulted as effective in the diagnosis of OSA (no significant differences in AHI). The use of a validated RP and not a PSG in Phase II is a limitation for the validation of the automatic scoring. Moreover, it would limit the estimation of the total sleep time, which was determined by the analysis of morphology of the respiratory flow wave and cardiac frequency. It is worth noting that automatic diagnosis never mistakenly classified patients with severe OSA as patients without OSA or as patients with mild OSA, and vice versa. This study's main strength is the large number of subjects enrolled in Phase I and the validation in another group of patients in Phase II. However, it also has some limitations. First, this is not a trial but an observational study. Second, Phase II was conducted on a small sample of patients. Third, a validated RP [37] [38] [39] and not PSG was used as a reference. This was to allow the sleep study to be performed at the patients' own home. Another limitation was the analysis of the sleep studies by only one technician. This prevents the measurement of the interobserver variability.
This study suggests that it is possible to perform automatic diagnosis of OSA by an RP device. The automatic BTI-APNiA RP was shown to be as accurate as the manual analysis in the diagnosis of OSA and has been validated against Embletta Gold RP. Further clinical trials are needed to confirm these observations. Companies and sleep specialists should cooperate to solve the public health problem posed by the current underdiagnosis of OSA. Reliable and efficient devices for automatic diagnosis of OSA could pave the road to achieve a better service to our patients. 
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